Stock market is reacting very positively to this vaccine. The journal paper and health analysts consider immune response to be significant after booster and side effects relatively minor in all participants. Yet here you're quoting a Twitter posts that is brought to the top of the discussion on HN despite being not a primary or secondary, but a tertiary source.